ISHARES TR - ISHARES BIOTECH (IBB)

Historical Portfolio Holders from Q1 2014 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / ISHARES BIOTECH
Shares, excl. options Q3 2024
35.2M
Holdings value Q3 2024
$5.13B
Value change Q3 2024
-$576M
Grand Portfolio weight change Q3 2024
-0.001%
Number of holders
864
Number of buys Q3 2024
302
Number of sells Q3 2024
-376
Average buys Q3 2024 %
+0.002%
Average sells Q3 2024 %
-0.003%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 35.2M $5.13B -$576M $145.60 877
2024 Q2 38.4M $5.28B +$1.49M $137.26 887
2024 Q1 38.6M $5.3B +$341M $137.22 885
2023 Q4 35.7M $4.85B -$427M $135.85 856
2023 Q3 38.5M $4.71B -$201M $122.29 820
2023 Q2 40.2M $5.1B -$166M $126.96 827
2023 Q1 41.3M $5.33B -$415M $129.16 849
2022 Q4 43.3M $5.69B +$653M $131.29 889
2022 Q3 39M $4.56B -$61.8M $116.96 817
2022 Q2 39.8M $4.68B -$150M $117.63 845
2022 Q1 41.3M $5.39B -$43.8M $130.30 879
2021 Q4 41.6M $6.34B -$355M $152.62 947
2021 Q3 43.8M $7.08B -$474M $161.68 845
2021 Q2 46.7M $7.64B -$738M $163.65 853
2021 Q1 50.8M $7.66B -$1.34B $150.56 837
2020 Q4 58.7M $8.89B +$1.05B $151.49 852
2020 Q3 54.5M $7.37B -$449M $135.41 778
2020 Q2 57.6M $7.87B +$1.19B $136.69 760
2020 Q1 47.1M $5.08B -$741M $107.74 661
2019 Q4 53.2M $6.41B -$15.9M $120.51 710
2019 Q3 52.8M $5.25B -$6.08M $99.50 595
2019 Q2 51.9M $5.66B +$178M $109.10 650
2019 Q1 49.7M $5.56B +$245M $111.80 665
2018 Q4 47.7M $4.6B -$272M $96.43 644
2018 Q3 51.6M $6.29B -$540M $121.94 640
2018 Q2 55.9M $6.14B +$257M $109.82 610
2018 Q1 54M $5.76B -$20.3M $106.74 616
2017 Q4 53.4M $5.71B +$3.31B $106.77 627
2017 Q3 19.3M $6.44B +$614M $333.59 579
2017 Q2 17.6M $5.46B +$106M $310.08 557
2017 Q1 17.2M $5.05B +$496M $293.27 517
2016 Q4 15.6M $4.13B -$145M $265.38 520
2016 Q3 16.1M $4.62B +$577M $289.46 458
2016 Q2 14.5M $3.73B -$155M $257.34 423
2016 Q1 14.8M $3.86B -$443M $260.81 410
2015 Q4 16.5M $5.55B -$1.69B $338.33 430
2015 Q3 21.2M $6.42B +$1.1B $303.33 408
2015 Q2 18M $6.63B -$259M $368.97 416
2015 Q1 18.7M $6.41B +$719M $343.43 392
2014 Q4 16.8M $5.09B -$692M $303.35 365
2014 Q3 18.9M $5.18B +$615M $273.63 314
2014 Q2 16.7M $4.29B -$588M $257.03 304
2014 Q1 19.1M $4.51B +$1.29B $236.40 287